Literature DB >> 11550776

Intracranial and mediastinal inflammatory myofibroblastic tumour.

C Crespo1, M Navarro, I González, M F Lorente, R González, M J Mayol.   

Abstract

Inflammatory myofibroblastic tumour (IMT) is a rare neoplastic condition, commonly known as inflammatory pseudotumour, which is the most frequent primary tumour of the lung in childhood. IMT can have an extrapulmonary location, but is infrequent in the brain and mediastinum, and it is extremely unusual that both lesions appear simultaneously as in our patient. The definitive diagnosis is established by biopsy, but there are some MRI findings that can be useful to identify the lesion.

Entities:  

Mesh:

Year:  2001        PMID: 11550776     DOI: 10.1007/s002470100489

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  4 in total

1.  Inflammatory myofibroblastic tumor of the posterior mediastinum: an older adult case with anaplastic lymphoma kinase abnormalities determined using immunohistochemistry and fluorescence in situ hybridization.

Authors:  Yoshifumi Makimoto; Kazuki Nabeshima; Hiroshi Iwasaki; Akiko Ishiguro; Tatsu Miyoshi; Takeshi Shiraishi; Akinori Iwasaki; Takayuki Shirakusa
Journal:  Virchows Arch       Date:  2005-03-19       Impact factor: 4.064

Review 2.  Inflammatory myofibroblastic tumour of the spinal cord: case report and review of the literature.

Authors:  M Despeyroux-Ewers; I Catalaâ; L Collin; C Cognard; F Loubes-Lacroix; C Manelfe
Journal:  Neuroradiology       Date:  2003-09-27       Impact factor: 2.804

Review 3.  Inflammatory myofibroblastic tumor in the intradural extramedullary space of the lumbar spine with spondylolisthesis: case report and review of the literature.

Authors:  Sang Hoon Yoon; Ki-Jeong Kim; Sang Ki Chung; Hyun-Jib Kim; Gheeyoung Choe; Sang Bong Chung; Yong Jun Jin
Journal:  Eur Spine J       Date:  2009-11-26       Impact factor: 3.134

Review 4.  Mesenchymal tumours of the mediastinum--part I.

Authors:  Michael A den Bakker; Alexander Marx; Kiyoshi Mukai; Philipp Ströbel
Journal:  Virchows Arch       Date:  2015-09-10       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.